Literature DB >> 18555236

No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.

Eleuterio R Hernández1, José Luis Gómez-Palomares, Elisabetta Ricciarelli.   

Abstract

We retrospectively studied 429 IVF donor cycles in which ovulation was triggered with either hCG (175 cycles) or GnRH agonist (254 cycles). Of the donors in whom ovulation was triggered with hCG, 3.2% developed symptoms of moderate (2.2%) or severe (1%) ovarian hyperstimulation syndrome, while none of the IVF donor cycles that were triggered with the GnRH agonist presented ovarian hyperstimulation syndrome, needed coasting, or were cancelled.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18555236     DOI: 10.1016/j.fertnstert.2008.03.077

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  A matched propensity score study of embryo morphokinetics following gonadotropin-releasing hormone agonist versus human chorionic gonadotropin trigger.

Authors:  Galia Oron; Onit Sapir; Avital Wertheimer; Yoel Shufaro; Roni Bar-Gil; Tamar Margalit; Ekaterina Shlush; Avi Ben-Haroush
Journal:  J Assist Reprod Genet       Date:  2020-09-27       Impact factor: 3.412

2.  GnRH analogues in the prevention of ovarian hyperstimulation syndrome.

Authors:  Pilar Alama; Jose Bellver; Carmen Vidal; Juan Giles
Journal:  Int J Endocrinol Metab       Date:  2013-04-01

3.  Oocyte competence is independent of the ovulation trigger adopted: a large observational study in a setting that entails vitrified-warmed single euploid blastocyst transfer.

Authors:  Danilo Cimadomo; Alberto Vaiarelli; Cecilia Petriglia; Gemma Fabozzi; Susanna Ferrero; Mauro Schimberni; Cindy Argento; Silvia Colamaria; Maddalena Giuliani; Nicolò Ubaldi; Laura Rienzi; Filippo Maria Ubaldi
Journal:  J Assist Reprod Genet       Date:  2021-03-04       Impact factor: 3.357

4.  Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial.

Authors:  Deepika Krishna; Snehal Dhoble; Gautham Praneesh; Suvarna Rathore; Amit Upadhaya; Kamini Rao
Journal:  J Hum Reprod Sci       Date:  2016 Jul-Sep

Review 5.  GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article.

Authors:  Ashraf Alyasin; Shayesteh Mehdinejadiani; Marzieh Ghasemi
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-09

Review 6.  Gonadotropin-releasing hormone agonist ovulation trigger-beyond OHSS prevention.

Authors:  Juan Carlos Castillo; Thor Haahr; María Martínez-Moya; Peter Humaidan
Journal:  Ups J Med Sci       Date:  2020-03-25       Impact factor: 2.384

7.  Evaluation of the safety and efficacy of corifollitropin alfa combined with GnRH agonist triggering in oocyte donation cycles. A prospective longitudinal study.

Authors:  Ioannis Tsakiridis; Robert Najdecki; Petroula Tatsi; Evi Timotheou; Kallirhoe Kalinderi; Georgios Michos; Andriana Virgiliou; Hakan Yarali; Apostolos Athanasiadis; Evangelos G Papanikolaou
Journal:  JBRA Assist Reprod       Date:  2020-10-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.